Click here to resize type

What is GlaucoCetin Medical Food

Q: What is GlaucoCetin Medical Food

GlaucoCetin is the first regulated vision-specific Medical Food designed to support and protect the mitochondrial function of optic nerve cells in patients with glaucoma. GlaucoCetin combines a unique set of ingredients, specifically designed to stop or reverse the underlying cause of optic nerve loss, and ultimately vision loss, in glaucoma. During the glaucomatous disease process, the metabolism for the optic nerve cells start to fail because of dysfunctional mitochondria. Mitochondria is responsible for energy production in these cells. When mitochondria is unable to function, the nerve cells do not have enough energy to operate, and they eventually die, causing vision loss.

GlaucoCetin is designed to support and protect the mitochondrial function of optic nerve cells. GlaucoCetin combines a unique set of ingredients, specifically designed to support, and prevent the underlying cause of optic nerve loss. The metabolism for the optic nerve cells start to fail because of dysfunctional mitochondria. Mitochondria are responsible for energy production in these cells. When mitochondria are unable to function, the nerve cells do not have enough energy to operate, and they eventually die, which may lead to less-than-optimal vision.

The GlaucoCetin formula has been under development for a decade and is based on years of research showing the importance of natural ingredients for protecting nerve cells. GlaucoCetin focuses on protecting these important nerve cells and has been used successfully since 2016.

Dr. Robert Ritch

Developer of the Precursor Compound for GlaucoCetin® (Glaucohealth™)

Chief, Glaucoma Services Emeritus and Surgeon Director Emeritus New York Eye and Ear Infirmary of Mount Sinai

American Academy of Ophthalmology Lifetime Achievement Award

Member, Academia Ophthalmologica Internationalis

*Co-Authored Nine Textbooks and more than 1800 Medical and Scientific Papers

GlaucoCetin was developed in collaboration with Dr Robert Ritch, a world-renowned glaucoma specialist from New York Eye and Ear Infirmary of Mount Sinai in New York City

*The Precursor to GlaucoCetin, Glaucohealth™, and all related formulas created by Dr Robert Ritch were acquired by Guardion Health Sciences in the second quarter of 2018 and subsequently renamed GlaucoCetin.